400
Participants
Start Date
March 17, 2022
Primary Completion Date
December 31, 2022
Study Completion Date
June 15, 2023
GuardantSHIELD Blood Test
The GuardantSHIELD CRC screening test is a commercially available test which works by finding signs of colorectal tumor in the blood of patients at average risk for CRC
Kaiser Permanente Northwest, Portland
Kaiser Permanente
OTHER